Cargando…
Potential benefits of medium chain fatty acids in aging and neurodegenerative disease
Neurodegenerative diseases are a large class of neurological disorders characterized by progressive dysfunction and death of neurones. Examples include Alzheimer’s disease, Parkinson’s disease, frontotemporal dementia, and amyotrophic lateral sclerosis. Aging is the primary risk factor for neurodege...
Autores principales: | Dunn, Ella, Zhang, Biqin, Sahota, Virender K., Augustin, Hrvoje |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481710/ https://www.ncbi.nlm.nih.gov/pubmed/37680538 http://dx.doi.org/10.3389/fnagi.2023.1230467 |
Ejemplares similares
-
Medium-Chain Fatty Acids Rescue Motor Function and Neuromuscular Junction Degeneration in a Drosophila Model of Amyotrophic Lateral Sclerosis
por: Dunn, Ella, et al.
Publicado: (2023) -
The Divergent Immunomodulatory Effects of Short Chain Fatty Acids and Medium Chain Fatty Acids
por: Sam, Qi Hui, et al.
Publicado: (2021) -
Medium-Chain Fatty Acids, Beta-Hydroxybutyric Acid and Genetic Modulation of the Carnitine Shuttle Are Protective in a Drosophila Model of ALS Based on TDP-43
por: Manzo, Ernesto, et al.
Publicado: (2018) -
Increased Accumulation of Medium-Chain Fatty Acids by Dynamic Degradation of Long-Chain Fatty Acids in Mucor circinelloides
por: Hussain, Syed Ammar, et al.
Publicado: (2020) -
Maximizing the Treatment Benefit of tDCS in Neurodegenerative Anomia
por: Roncero, Carlos, et al.
Publicado: (2019)